מדינה: הממלכה המאוחדת
שפה: אנגלית
מקור: MHRA (Medicines & Healthcare Products Regulatory Agency)
Citalopram hydrobromide
Viatris UK Healthcare Ltd
N06AB04
Citalopram hydrobromide
40mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04030300; GTIN: 5016695291765 5016695009018
FERTILITY: Citalopram has been shown to reduce the quality of sperm in animal studies. Theoretically, this could affect fertility, but impact on human fertility has not been observed as yet. DRIVING AND USING MACHINES: Citalopram may have side effects like dizziness and lack of concentration. You should not drive or operate machinery if affected CITALOPRAM TABLETS CONTAIN LACTOSE: These tablets contain lactose. If you have been told that you have intolerance to some sugars, contact your doctor before taking these tablets. 3. HOW TO TAKE CITALOPRAM TABLETS Always take Citalopram Tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Swallow the tablets whole. Do not crush them. The tablets can be taken either in the morning or in the evening, before or after a meal. The usual oral dose is: ADULTS Depression: The usual dose is 20 mg per day. This may be increased by your doctor to a maximum of 40 mg per day. Panic Disorder: The starting dose is 10 mg per day for the first week before increasing the dose to 20-30 mg per day. The dose may be increased by doctor to a maximum of 40 mg per day. ELDERLY PATIENTS (ABOVE 65 YEARS OF AGE): The starting dose should be decreased to half of the recommended dose, e.g. 10-20 mg per day. Elderly patients should not usually receive more than 20 mg per day. CHILDREN AND ADOLESCENTS (< 18 YEARS): This medicine is not recommended for children. For further information, please see section 2, BEFORE YOU TAKE CITALOPRAM TABLETS PATIENTS WITH SPECIAL RISKS: Patients with liver complaints should not receive more than 20 mg per day. PATIENTS WITH KIDNEY DISEASE: No dosage adjustment is required in mild or moderate kidney impairment. In severe renal impairment, your doctor may adjust your dose. HOW AND WHEN TO TAKE CITALOPRAM TABLETS: Citalopram Tablets is taken every day as a single daily dose. Citalopram Tablets can be taken any time of the day with or without food. Swallow the tablets with a drink of water. Do not chew them (they קרא את המסמך השלם
1. NAME OF THE MEDICINAL PRODUCT CITALOPRAM 40mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 film-coated_ _tablet contains 49.98 mg citalopram hydrobromide, equivalent to 40 mg citalopram. For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablets Round, white film-coated tablets with a break-line and diameter of 10 mm. The tablet can be divided into equal doses. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of major depressive episodes. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Following treatment initiation, an antidepressant effect should not be expected for at least two weeks. Treatment should continue until the patient has been free of symptoms for 4-6 months. Citalopram should be withdrawn slowly; it is advised that the dose is gradually reduced over 1-2 week periods. _Paediatric population _ Citalopram should not be used in the treatment of children and adolescents under the age of 18 years (see section 4.4). _Adults _ The recommended starting dose is 20 mg per day. If necessary, the dose can be increased to a maximum of 40 mg per day, depending on the individual response of the patient. _Elderly patients (>65 years of age) _ For elderly patients the dose should be decreased to half of the recommended dose, e.g. 10- 20 mg daily. Depending on the individual response of the patient, the dose can be increased. The recommended maximum dose for the elderly is 20 mg daily. _Reduced renal function _ Dosage adjustment is not required if the patient has mild to moderate renal impairment. Caution is advised in patients with severe renal impairment (creatinine clearance less than 30ml/min, see section 5.2). _Reduced hepatic function _ An initial dose of 10 mg daily for the first two weeks of treatment is recommended in patients with mild or moderate hepatic impairment. Depending on individual patient response, the dose may be increased to a maximum of 20 mg daily. Caution and extra careful dose titration is advised in patients with severely reduced hep קרא את המסמך השלם